Showing 36,421 - 36,440 results of 66,085 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((teer decrease) OR (mean decrease)) ))', query time: 1.53s Refine Results
  1. 36421

    Effects of PPS on the expression of glutamic acid decarboxylase 65/67 (GAD6) in the amygdala of rats. by Stamatina Tzanoulinou (552258)

    Published 2014
    “…Optical densitometry of neuropil immunoreactivity revealed a significant decrease of GAD protein levels in the amygdala of PPS animals as compared to CTRL (D). ** p<0.01 versus CTRL, results are the mean ± SEM.…”
  2. 36422
  3. 36423
  4. 36424
  5. 36425
  6. 36426
  7. 36427

    FRAP analysis reveals PFN1 as major regulator of actin dynamics in astrocytic processes. by Stefanie K. Schweinhuber (687289)

    Published 2015
    “…Significance is indicated as follows *p<0.05; **p<0.01; ***p<0.001. Data are shown as mean ± SEM.…”
  8. 36428

    Molecular mechanisms of impaired intestinal barrier function. by Tim Vanuytsel (513970)

    Published 2014
    “…(E) Western Blot analysis at 50 days shows decreased CLDN1 expression and a tendency towards increased CLDN2 expression (P = 0.07) in BB-DP rats (white bars) compared to controls (black bars). …”
  9. 36429

    Table1_Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats.DOCX by Min Zhou (173135)

    Published 2022
    “…Storax treatment of 0.2, 0.4, and 0.8 g/kg led to a significant decrease in infarction size, and the Storax 0.4, 0.8 g/kg groups displayed a significant reduction in brain water content. …”
  10. 36430
  11. 36431
  12. 36432
  13. 36433
  14. 36434
  15. 36435
  16. 36436
  17. 36437
  18. 36438
  19. 36439
  20. 36440